13 results
8-K
EX-99.1
GUTS
Fractyl Health, Inc. Common Stock
14 Aug 24
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
4:05pm
and 2023 was generated from the Company's pilot commercial launch in Germany.
R&D Expenses: Research and development expense was $16.8 million … Months Ended
June 30,
Revenue
Cost of goods sold
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Total
10-Q
2024 Q1
GUTS
Fractyl Health, Inc. Common Stock
13 May 24
Quarterly report
4:06pm
and per share information)
Three Months Ended March 31,
Revenue
Cost of goods sold
Gross profit
Operating expenses:
Research and development
Selling … payable, the fair value of stock-based awards, the incremental borrowing rate for lease accounting and the accrual of research and development expenses
8-K
EX-99.1
GUTS
Fractyl Health, Inc. Common Stock
13 May 24
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
4:01pm
in Germany that was initiated in the first quarter of 2023.
R&D Expenses: Research and development expense was $14.4 million for the quarter ended March 31 … Loss
(in thousands)
(Unaudited)
Three Months Ended
March 31,
Revenue
Cost of goods sold
Gross profit
Operating expenses:
Research and development
10-K
2023 FY
GUTS
Fractyl Health, Inc. Common Stock
1 Apr 24
Annual report
7:15am
and financial position, business strategy, prospective products, product approvals, research and development costs, future revenue, timing and likelihood … preparatory work, the period during which the results of the studies will become available and our research and development programs;
the timing
8-K
EX-99.1
t8vej6fj151stvhvumr
1 Apr 24
Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:10am
424B4
jgbbat3klp5x28jsk60k
2 Feb 24
Prospectus supplement with pricing info
4:18pm
S-1/A
2p8gblxx ocr
29 Jan 24
IPO registration (amended)
6:09am
S-1/A
EX-10.9
10f pps59gdxqd
29 Jan 24
IPO registration (amended)
6:09am
S-1
EX-10.11
g5d fepiok4e1
14 Dec 23
IPO registration
3:39pm
S-1
jl630wa1ipszv
14 Dec 23
IPO registration
3:39pm
DRS/A
6zgvg4xnj3l611 n4vkw
21 Sep 23
Draft registration statement (amended)
12:00am
DRS/A
wody8cwm1ufg
22 Aug 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next